CG FV (Femara 2.5 mg)
Generic Name: letrozole
Pill imprint CG FV has been identified as Femara 2.5 mg.
Femara is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant; female infertility and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Femara 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for CG FV (Femara 2.5 mg)
- Generic Name:
- 2.5 mg
- 7.00 mm
- Prescription only
- Drug Class:
- Aromatase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide red
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|54868-4151||Physicians Total Care Inc (repackager)|
|54569-5714||A S Medication Solutions LLC (repackager)|
|35356-0409||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
Femara is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...